• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾日布林治疗转移性子宫平滑肌肉瘤后的肿瘤溶解综合征。

Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma.

作者信息

Pabon Cindy, Esnakula Ashwini K, Daily Karen

机构信息

College of Medicine, University of Florida, Gainesville, Florida, USA.

Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.

出版信息

BMJ Case Rep. 2018 Dec 19;11(1):e224576. doi: 10.1136/bcr-2018-224576.

DOI:10.1136/bcr-2018-224576
PMID:30573532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6303597/
Abstract

A middle-aged woman with a history of leiomyosarcoma of the uterus treated with surgery and adjuvant chemotherapy suffered a bulky metastatic recurrence 1 year later. She elected treatment with palliative eribulin, presenting with acute renal failure and electrolyte abnormalities consistent with tumour lysis syndrome on cycle 1 day 8. Despite aggressive supportive care and treatment including intravenous hydration, bicarbonate and rasburicase, she continued to decline, ultimately foregoing haemodialysis in favour of palliative care and passed away in the hospital.

摘要

一名有子宫平滑肌肉瘤病史的中年女性接受了手术及辅助化疗,1年后出现大量转移性复发。她选择接受姑息性艾日布林治疗,在第1周期第8天出现急性肾衰竭及与肿瘤溶解综合征相符的电解质异常。尽管给予了积极的支持治疗,包括静脉补液、碳酸氢盐和重组尿酸氧化酶,但她的病情仍持续恶化,最终放弃血液透析而选择姑息治疗,并在医院去世。

相似文献

1
Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma.艾日布林治疗转移性子宫平滑肌肉瘤后的肿瘤溶解综合征。
BMJ Case Rep. 2018 Dec 19;11(1):e224576. doi: 10.1136/bcr-2018-224576.
2
Tumor Lysis Syndrome due to Eribulin Administration for Metastatic Undifferentiated Pleomorphic Sarcoma of the Buttock.因使用艾瑞布林治疗臀部转移性未分化多形性肉瘤导致的肿瘤溶解综合征。
Acta Med Okayama. 2021 Aug;75(4):533-538. doi: 10.18926/AMO/62408.
3
Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case report.转移性子宫平滑肌肉瘤患者使用艾日布林的疗效:病例报告。
Future Oncol. 2020 Jan;16(1s):15-19. doi: 10.2217/fon-2019-0597. Epub 2020 Jan 9.
4
FDA Approval Summary: Eribulin for Patients with Unresectable or Metastatic Liposarcoma Who Have Received a Prior Anthracycline-Containing Regimen.FDA 批准概要:对于既往接受过含蒽环类药物方案治疗的无法切除或转移性脂肪肉瘤患者,给予艾立布林治疗。
Clin Cancer Res. 2017 Nov 1;23(21):6384-6389. doi: 10.1158/1078-0432.CCR-16-2422. Epub 2017 Feb 27.
5
A tumour lysis syndrome in a chemotherapy naïve patient with metastatic pancreatic adenocarcinoma.一名初治转移性胰腺腺癌患者发生肿瘤溶解综合征。
BMJ Case Rep. 2015 Jan 29;2015:bcr2014207748. doi: 10.1136/bcr-2014-207748.
6
A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation.一例子宫上皮样平滑肌肉瘤伴局灶性横纹肌肉瘤样分化化疗后发生肿瘤溶解综合征的病例。
J Obstet Gynaecol Res. 2011 Jul;37(7):947-52. doi: 10.1111/j.1447-0756.2010.01454.x. Epub 2011 Mar 16.
7
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.贝伐昔福肽联合艾瑞布林治疗人表皮生长因子受体 2 阴性转移性乳腺癌的 1 期、单臂、剂量递增试验。
Lancet Oncol. 2018 Jun;19(6):812-824. doi: 10.1016/S1470-2045(18)30147-5. Epub 2018 Apr 26.
8
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.甲磺酸艾日布林治疗软组织肉瘤患者的疗效:四种独立组织学亚型的 II 期研究。
Lancet Oncol. 2011 Oct;12(11):1045-52. doi: 10.1016/S1470-2045(11)70230-3. Epub 2011 Sep 19.
9
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma.一位经大量预处理的脂肪肉瘤患者延迟使用艾日布林,此前该患者被误诊为平滑肌肉瘤。
Future Oncol. 2020 Jan;16(1s):9-13. doi: 10.2217/fon-2019-0596. Epub 2020 Jan 9.
10
Eribulin in advanced liposarcoma and leiomyosarcoma.艾日布林用于晚期脂肪肉瘤和平滑肌肉瘤的治疗
Expert Rev Anticancer Ther. 2017 Aug;17(8):717-723. doi: 10.1080/14737140.2017.1344098. Epub 2017 Jun 28.

引用本文的文献

1
Tumor Lysis Syndrome in Patients With Solid Tumors: A Systematic Review of Reported Cases.实体瘤患者的肿瘤溶解综合征:已报道病例的系统评价
Cureus. 2022 Oct 25;14(10):e30652. doi: 10.7759/cureus.30652. eCollection 2022 Oct.

本文引用的文献

1
Spontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung Metastases.子宫平滑肌肉瘤伴肺转移导致的自发性肿瘤溶解综合征
Case Rep Crit Care. 2017;2017:4141287. doi: 10.1155/2017/4141287. Epub 2017 Sep 11.
2
Eribulin in advanced liposarcoma and leiomyosarcoma.艾日布林用于晚期脂肪肉瘤和平滑肌肉瘤的治疗
Expert Rev Anticancer Ther. 2017 Aug;17(8):717-723. doi: 10.1080/14737140.2017.1344098. Epub 2017 Jun 28.
3
Tumor Lysis Syndrome: A Unique Solute Disturbance.肿瘤溶解综合征:一种独特的溶质紊乱。
Nurs Clin North Am. 2017 Jun;52(2):309-320. doi: 10.1016/j.cnur.2017.01.008. Epub 2017 Apr 7.
4
Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.艾瑞布林用于既往治疗过的晚期或转移性软组织肉瘤患者的2期研究。
Jpn J Clin Oncol. 2017 Feb 1;47(2):137-144. doi: 10.1093/jjco/hyw175.
5
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
6
Tumor lysis syndrome: A clinical review.肿瘤溶解综合征:临床综述
World J Crit Care Med. 2015 May 4;4(2):130-8. doi: 10.5492/wjccm.v4.i2.130.
7
Tumor lysis syndrome: new challenges and recent advances.肿瘤溶解综合征:新的挑战与最新进展。
Adv Chronic Kidney Dis. 2014 Jan;21(1):18-26. doi: 10.1053/j.ackd.2013.07.001.
8
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).高级别、子宫局限性平滑肌肉瘤的辅助治疗:一项 2 期试验(SARC 005)的结果。
Cancer. 2013 Apr 15;119(8):1555-61. doi: 10.1002/cncr.27942. Epub 2013 Jan 18.
9
Paradigm shift in the role of uric acid in acute kidney injury.尿酸在急性肾损伤中的作用的范式转变。
Semin Nephrol. 2011 Sep;31(5):453-8. doi: 10.1016/j.semnephrol.2011.08.010.
10
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.甲磺酸艾日布林治疗软组织肉瘤患者的疗效:四种独立组织学亚型的 II 期研究。
Lancet Oncol. 2011 Oct;12(11):1045-52. doi: 10.1016/S1470-2045(11)70230-3. Epub 2011 Sep 19.